Need Help? Talk to an Expert +1 (408) 836-7136

Adaptimmune Therapeutics PLC

CIK Ticker Name Accession Number Date Form
1621227 Adaptimmune Therapeutics PLC 0001104659-25-039042 2025-04-25 08:02:51 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-25-034899 2025-04-15 08:00:40 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-24-046093 2024-04-11 08:00:34 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-24-041530 2024-04-01 08:01:26 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-23-044825 2023-04-13 08:00:53 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-23-040544 2023-04-03 08:00:39 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-22-048084 2022-04-21 08:00:17 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-22-044463 2022-04-11 08:00:26 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-21-047833 2021-04-08 08:00:34 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-21-042777 2021-03-29 08:00:32 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-20-048476 2020-04-20 08:00:42 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001104659-20-044488 2020-04-08 08:00:26 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001047469-19-001324 2019-03-15 17:01:49 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001047469-19-000849 2019-03-01 17:01:29 PRE 14A
1621227 Adaptimmune Therapeutics PLC 0001047469-18-003307 2018-04-27 17:00:50 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001047469-17-003061 2017-04-28 16:48:52 DEF 14A
1621227 Adaptimmune Therapeutics PLC 0001047469-17-002518 2017-04-11 20:19:58 PRE 14A